For research use only. Not for therapeutic Use.
Viaminate is a derivative of Retinoic acid, which is used for the treatment of severe acne and other keratinization disorders.
Viaminate is an amide compound formed by Tretinoin and Ethyl p-aminobenzoate, in which the end group of Tretinoin is transformed into amide and ester chain[1].
| Catalog Number | I040707 |
| CAS Number | 53839-71-7 |
| Synonyms | ethyl 4-[[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoate |
| Molecular Formula | C29H37NO3 |
| Purity | ≥95% |
| InChI | InChI=1S/C29H37NO3/c1-7-33-28(32)24-14-16-25(17-15-24)30-27(31)20-22(3)11-8-10-21(2)13-18-26-23(4)12-9-19-29(26,5)6/h8,10-11,13-18,20H,7,9,12,19H2,1-6H3,(H,30,31)/b11-8+,18-13+,21-10+,22-20+ |
| InChIKey | VRSMJNVXOITYPE-FSDIUQKZSA-N |
| SMILES | CCOC(=O)C1=CC=C(C=C1)NC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C |
| Reference | [1]. Zhang H, et al. Fatal Hepatotoxicity Due to Viaminate. Am J Med Sci. 2018 Jul;356(1):84-86. |
